COVID-19 Vaccine Booster Trial Blinded Elixir from Germany
Blinded liquid elixir placebo for oral intake in Phase IV COVID-19 booster trials, in 10ml sachets mimicking vaccine adjuvant taste profile. Falls under HTS 3006.93.60.00 as double-blinded clinical trial material in measured oral doses.
Duty Rate — Germany → United States
0%
Rate breakdown
9903.03.030%Articles the product of any country, as provided for in subdivision (aa)(ii) of U.S. note 2 to this subchapter
Import Tips
• Provide emergency use authorization or IND linked to public health emergency trials for expedited clearance
• Label with trial phase and sponsor to distinguish from waste pharmaceuticals under 3006(k)
• Test for alcohol content if any, to avoid Chapter 22 reclassification